Recent clinical trials of gene therapy for patients with thoracic cancers have shown that these treatments were well tolerated with minimal side effects and that we need to further enhance specificity as well as efficiency of gene transfer to target cancer cells. We previously reported that mycovere
โฆ LIBER โฆ
Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells
โ Scribed by Satoshi Okabe; Takehiro Arai; Hironori Yamashita; Kenichi Sugihara
- Publisher
- Springer-Verlag
- Year
- 2003
- Tongue
- English
- Weight
- 408 KB
- Volume
- 129
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Adenovirus-mediated gene therapy specifi
โ
Kazumi Nishino; Tadashi Osaki; Toru Kumagai; Takashi Kijima; Isao Tachibana; Hir
๐
Article
๐
2001
๐
John Wiley and Sons
๐
French
โ 127 KB
๐ 2 views
Gene therapy for ฮฑ-fetoprotein-producing
โ
F Kanai; Y Shiratori; Y Yoshida; H Wakimoto; H Hamada; Y Kanegae; I Saito; H Nak
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 422 KB
lacZ gene driven by the b-actin -based promoter. Ex-SEE EDITORIAL ON PAGE 1696. pression of the HSVtk gene by adenovirus from AFP promoter/enhancer (AdAFPtk) induced the cells sensitive to ganciclovir (GCV) in the AFP-producing cell We have developed a recombinant replication-deline efficiently, but